Home
>ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl
Compare
Equity
Direct
Sector - Healthcare
NAV: ₹ 15 as on 03-02-2023
Fund Performance
Fund Performance as on (19-Jan-23)
About the Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is an equity fund. This fund was started on 12 July, 2018. The fund is managed by Dharmesh Kakkad, Sharmila D’mello. The fund could potentially beat inflation in the long-run.
Key parameters
1) ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl has a NAV of ₹14.96 as on 03-02-2023.
2) ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl has ₹2514 Cr worth of assets under management (AUM) as on 31-12-2022 and is more than category average.
3) The fund has an expense ratio 1.21 %.
Fund Overview
Expense ratio | 1.21% |
Benchmark | S&P BSE Healthcare PR |
AUM | ₹2514 Cr |
Inception Date | 12 July, 2018 |
Min Lumpsum/SIP | ₹5000/₹0 |
Exit Load | 1% |
Lock In | No Lock-in |
TurnOver | 50.98% |
Fund Distribution as on (31-Dec-22)
Size breakup
Large cap
44.3%
Mid cap
29%
Small cap
24%
Sector Allocation
Health
95.6%
Financial Services
4.4%
Top Holdings as on (31-Dec-22)
Equity Holdings31
Debt Holdings3
See all
What changed
in last one month
AUM decreased by 90.3 Cr in last 1M
Dec'22 return underperformed benchmark
Change in AUM
Dec'22
₹ 2.5K Cr
Nov'22
₹ 2.6K Cr
Oct'22
₹ 2.6K Cr
Fund Returns vs Benchmark
Jan'23
2.85%
5.37%
Dec'22
0.82%
2.63%
Nov'22
2.85%
5.37%
Fund Return
Benchmark Return
Concentration Analysis as on (31-Dec-22)
Winners & Losers as on (31-Dec-22)
Top Growth Drivers | 1M Return |
|---|---|
Indoco Remedies Ltd | 3% |
Sanofi India Ltd | 2.9% |
Zydus Lifesciences Ltd | 2.1% |
Peer Analysis
Fund Manager
Dharmesh Kakkad
Fund Manager of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl, since 2 May 2020
Top funds managed
Sharmila D’mello
Fund Manager of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl, since 31 July 2022
Top funds managed
AMC details
Fund House
ICICI Prudential Asset Management Company Limited
Total Schemes
Total AUM
₹4.81L Cr
as on 31-Dec-2022
Address
ICICI Prudential Asset Mgmt.Company Limited,3rd Floor, Hallmark Business Plaza,,Sant Dyaneshwar Marg,,Bandra (East)
Phone
+912226428000
Email
enquiry@icicipruamc.com
Fund Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 13.41% since inception which is less than its category average return of 14.87%
Fund Allocations
This fund has an allocation of 97.23% in Equity, 0% in Debt and 2.77% in Cash related instruments
AUM size ₹2514 Cr
This fund has AUM of ₹2514 Cr which is more than its category average of ₹ 1318 Cr
Expense Ratio 1.21%
This fund has an expense ratio of 1.21% which is less than its category average expense ratio of 1.54%
Frequently Asked Questions
The current NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is 14.96 as on 03-Feb-2023.
Existing (Absolute + CAGR)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl | Absolute Returns | CAGR Returns |
1 Month Returns | -3.73% | -3.73% |
6 Month Returns | -2.72% | -2.72% |
1 Year Returns | -7.66% | -7.66% |
3 Years Returns | 63.55% | 17.82% |
5 Years Returns | 0% | 0% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
1.21 as on January 2023
2514 Cr as on January 2023
Sun Pharmaceuticals Industries Ltd(16.94%),Dr Reddy's Laboratories Ltd(8.26%),Lupin Ltd(5.09%),Apollo Hospitals Enterprise Ltd(4.91%),Alkem Laboratories Ltd(4.81%) as on January 2023
Health(92.92%),Financial Services(4.31%),Cash Equivalent(2.77%) as on January 2023
The alpha ratio for the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl | -0.31 | 0.23 | - |
As on January 2023
The alpha for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl | 0.89 | 0.97 | - |
As on January 2023
The Beta for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl | -0.76 | 0.64 | - |
As on January 2023
The sharpe ratio for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl | 12.67 | 22.73 | - |
As on January 2023
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.37 as on January 2023. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Dharmesh Kakkad,Sharmila D’mello are the fund managers of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl
The Exit load of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Dir Payout of Inc Dist cum Cap Wdrl is 1%
Mutual Fund execution provided by
Technology facilitation Services provided by Finzoom Investment Advisors Pvt. Ltd. - Advisory unit. SEBI Registered Investment Advisor: INA100012190 | BASL Registration No. 1154 | BSE StarMF Platform code: 24801
Disclaimer: Mutual Fund investments are subject to market risks, read all scheme related documents carefully. Past performance is not indicative of future returns.